MK-8808

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-8808, covering 2015-11-25 to 2016-07-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002) [Phase 1]